Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer.
Reed, N
Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer. [electronic resource] - Clinical oncology (Royal College of Radiologists (Great Britain)) 05 2020 - e145-e153 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1433-2981
10.1016/j.clon.2019.11.010 doi
Antineoplastic Agents--adverse effects
Consensus
Disease Management
Drug-Related Side Effects and Adverse Reactions--etiology
Expert Testimony
Humans
Phenylurea Compounds--adverse effects
Quinolines--adverse effects
Thyroid Neoplasms--drug therapy
Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer. [electronic resource] - Clinical oncology (Royal College of Radiologists (Great Britain)) 05 2020 - e145-e153 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1433-2981
10.1016/j.clon.2019.11.010 doi
Antineoplastic Agents--adverse effects
Consensus
Disease Management
Drug-Related Side Effects and Adverse Reactions--etiology
Expert Testimony
Humans
Phenylurea Compounds--adverse effects
Quinolines--adverse effects
Thyroid Neoplasms--drug therapy